Financhill
Back

Clinuvel Pharmaceuticals Ltd. 10K Form

Sell
38

CLVLY
Clinuvel Pharmaceuticals Ltd.

Last Price:
$8.15
Seasonality Move:
1.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLVLY News And Ratings

See the #1 stock for the next 7 days that we like better than CLVLY

CLVLY Financial Statistics

Sales & Book Value

Annual Sales: $61.5M
Cash Flow: $0
Price / Cash Flow: 15.85
Annual Sales: $2.70
Price / Book: 2.88

Profitability

EPS (TTM): 0.46550
Net Income (TTM): $23.3M
Gross Margin: $40.5M
Return on Equity: 19.45%
Return on Assets: 17.14%

Clinuvel Pharmaceuticals Ltd. Earnings Forecast

Key Clinuvel Pharmaceuticals Ltd. Financial Ratios

  • The Gross Profit Margin over the past 25 years for CLVLY is 65.78%.
  • The Selling, General & Administrative Expenses for CLVLY have been equal to 14.51% of Gross Profit Margin.
  • The Research & Development expenses have been 7.79% of Revenue.
  • The Interest Expense is 0.11% of Operating Income.
  • The Net Earning history of CLVLY is 38.07% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 15 years.

Clinuvel Pharmaceuticals Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLVLY
Website: clinuvel.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 17.37
Quick Ratio: 16.37

Price-to-Earnings

Trailing P/E Ratio: 17.52
Forward P/E Ratio: 0

CLVLY Technical Analysis vs Fundamental Analysis

Sell
38
Clinuvel Pharmaceuticals Ltd. (CLVLY) is a Sell

Is Clinuvel Pharmaceuticals Ltd. a Buy or a Sell?